Younossi, Zobair M.

Opportunities and challenges following approval of resmetirom for MASH liver disease

Lazarus, J. V., Ivancovsky Wajcman, D., Mark, H. E., Younossi, Z. M., Kopka, C. J., Cohen, N., Bansal, M. B., Betel, M., & Brennan, P. N. (2024) · Nature Medicine

Liver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and Protection

Cited by 60

Development and validation of a primary sclerosing cholangitis–specific patient‐reported outcomes instrument: The PSC PRO

Younossi, Z. M., Afendy, A., Stepanova, M., Racila, A., Nader, F., Gomel, R., Safer, R., Lenderking, W. R., Skalicky, A., Kleinman, L., et al. (2018) · Hepatology

Liver Diseases and ImmunityInflammatory Bowel Disease

Cited by 48

Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C

Younossi, Z. M., Stepanova, M., Afendy, M., Lam, B. P., & Mishra, A. (2013) · Journal of Viral Hepatitis

Hepatitis C virus researchHelicobacter pylori-related gastroenterology studies

Cited by 42

A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease

Ivancovsky Wajcman, D., Byrne, C. J., Dillon, J. F., Brennan, P. N., Villota-Rivas, M., Younossi, Z. M., Allen, A. M., Crespo, J., Gerber, L. H., & Lazarus, J. V. (2026) · Hepatology

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 33

Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)

Golabi, P., Stepanova, M., Pham, H. T., Cable, R., Rafiq, N., Bush, H., Gogoll, T., & Younossi, Z. M. (2018) · BMJ Open Gastroenterology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 32

Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials

Wong, V. W.-S., Tak, W. Y., Goh, G. B. B., Cheng, P.-N., Lawitz, E. J., Younossi, Z. M., Vuppalanchi, R., Younes, Z., Alkhouri, N., Wang, L., et al. (2023) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 31

Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis: Data From Real-world US Database

Younossi, Z. M., Stepanova, M., Golabi, P., Epstein, R. S., Strauss, M. E., Nader, F., & Racila, A. (2019) · Journal of Clinical Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 18

Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment†

Spiegel, B. M. R., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005) · Hepatology

Hepatitis C virus researchHealth Systems, Economic Evaluations, Quality of Life

Cited by 7